Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- BTE +12.8%, TNTR +10.4%, AMRC +10.2%, ALOG +10.1%, TEDU +8.3%, HAIR +6.3%,BZUN +6.3%, NX +5.2%, EGLE +4.8%, PQ +4.2%, YY +3.5%, CARS +3.5%, ANAB+2.5%, KLXI +2.4%, CIEN +2.3%, PARR +1.8%, NVGS +1.8%, LOGI +1.1%, (guidance),FAST +0.5%, (Feb Sales)
M&A news:
- CAG +1.9% (ConAgra responds to FTC decision to challenge the sale of Wesson oil to The J.M. Smucker - disagrees with the Commission's decision; to review all of options)
Other news:
- QDEL +5.1% (receives FDA clearance for its point-of-care Sofia Lyme Fluorescent Immunoassay)
- TI +4.3% (indicated higher on reports of Paul Singer' Elliott Management stake)
- MU +2.2% (positive Cramer mention)
- HL +1.9% (receives $31.6 million loan investment in Hecla from Ressources Quebec)
- BOJA +1.8% (CEO Clifton Rutledge resigns for personal reasons; co puts current Director James "Randy" Kibler in place as Interim President and CEO), GOGO +1.5% (CEO Michael Small steps down, co appoints appoints Oakleigh Thorne as President and CEO)
- ADRO +1.5% (earned a $3.0 mln development milestone payment under its worldwide licensing agreement with Merck for the initiation of a Phase I clinical trial of its anti-CD27 antibody)
- GSK +1.3% (reports new clinical data demonstrate high vaccine efficacy of Fluarix Tetra in children 6-35 months of age)
Analyst comments:
- GNCA +25.2% (initiated with a Overweight at Cantor Fitzgerald)
- MYL +3.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- HLF +2.9% (upgraded to Buy from Neutral at Citigroup)
- ALB +2.1% (upgraded to Buy from Neutral at Seaport Global Securities)
- UPS +2% (upgraded to Buy from Hold at Stifel)
- BG +1.6% (upgraded to Buy from Neutral at Citigroup)
- NTAP +1.5% (added to US 1 List at BofA/Merrill)
- ADM +1.2% (upgraded to Buy from Neutral at Citigroup)